Evidence map›Paper›PMID 28179412›Full record

ReviewMolecular & cellular proteomics : MCP2017

Sharpening Host Defenses during Infection: Proteases Cut to the Chase.

Natalie C Marshall, B Brett Finlay, Christopher M Overall

Open access · hybridAbstract readReview
In one paragraph

Review in Molecular & cellular proteomics : MCP, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. SpyCEP dismantles neutrophil immunity via disorder-driven chemokine remodeling and GAG targeting.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Cross-Talk Between the Intestinal Epithelium andFrontiers in microbiology · 2022
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Natalie C MarshallFrom the ‡Department of Microbiology & Immunology.ORCID 0000-0002-0303-7226
B Brett FinlayFrom the ‡Department of Microbiology & Immunology.
Christopher M Overall¶Department of Biochemistry & Molecular Biology, chris.overall@ubc.ca.ORCID 0000-0001-5844-2731
Upsher-Smith Laboratories (United Kingdom) · GBUniversity of British Columbia · CA

Funding

CIHR FDN-148408CIHR MOP-13356CIHR MOP-136976
6 · The paper itself

Abstract

The human immune system consists of an intricate network of tightly controlled pathways, where proteases are essential instigators and executioners at multiple levels. Invading microbial pathogens also encode proteases that have evolved to manipulate and dysregulate host proteins, including host proteases during the course of disease. The identification of pathogen proteases as well as their substrates and mechanisms of action have empowered significant developments in therapeutics for infectious diseases. Yet for many pathogens, there remains a great deal to be discovered. Recently, proteomic techniques have been developed that can identify proteolytically processed proteins across the proteome. These "degradomics" approaches can identify human substrates of microbial proteases during infection

Indexed as

Clostridium botulinumClostridium tetaniCommunicable DiseasesHost-Pathogen InteractionsHumansPeptide HydrolasesProteolysisProteomeProteomicsSubstrate SpecificityTetanus ToxinPeptide HydrolasesProteomeTetanus Toxin

Identifiers

PMID28179412
PMCPMC5393396
OpenAlexW2586660180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.